ARID4B and myalgic encephalomeyelitis/chronic fatigue syndrome: It is seems likely that mTORC1 activity upregulates BCAA degradation while mTORC1 itself is activated by other phenomena in ME/CFS lymphoblasts, such as the increased mitochondrial degradation of glutamine.